AxoGen (AXGN) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. QGEN

Go back to AxoGen (AXGN) Reports In-Line Q3 EPS

AxoGen, Inc. Reports 2018 Third Quarter Financial Results

October 29, 2018 4:01 PM EDT

Q3 Revenue of $22.7 million, representing 41% growth over prior year; Management reiterates full year 2018 guidance and introduces 2019 guidance

ALACHUA, Fla., Oct. 29, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today reported financial results and business highlights for the third quarter ended September 30, 2018.

Third Quarter 2018 Financial Results and Recent Business Highlights

Revenue of $22.7 million, up 41% compared to $16.0 million in the third... More